Physician profile
Christy E Benson
NPI 1265726913
$69,627.20
in general payments reported to CMS, 2019-2025
18 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $264 · 2021: $618 · 2022: $986 · 2023: $3,839 · 2024: $44K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Food and Beverage: $5,072 · Travel and Lodging: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,409.38 |
| Food and Beverage | $5,071.51 |
| Travel and Lodging | $851.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $65,236.08 | 2021-2025 | Idose, Istent Inject Trabecular Micro-Bypass System Model G2-M-Is, Travoprost Intraocular Implant - Idose |
| Alcon Vision LLC | $1,338.06 | 2019-2025 | Centurion, Unity, Clareon |
| Allergan, INC. | $398.62 | 2019-2021 | |
| Horizon Therapeutics Plc | $392.95 | 2022-2023 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $368.81 | 2024-2025 | Xdemvy |
| Livanova USA, INC. | $316.60 | 2023-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy Symmetry Model 8103 Generator |
| Amgen INC. | $271.59 | 2024-2025 | Tepezza |
| Abbvie INC. | $260.10 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $209.77 | 2022-2023 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $171.56 | 2019-2021 | |
| Biotissue Holdings INC. | $143.82 | 2024 | |
| Aerie Pharmaceuticals, INC. | $121.74 | 2021 | |
| Sight Sciences, INC. | $100.27 | 2022 | |
| Ani Pharmaceuticals, INC. | $86.48 | 2025 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $82.78 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $49.80 | 2025 | Vyepti |
| New World Medical,INC. | $45.96 | 2022 | |
| The Cameron-Ehlen Group, INC. | $32.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.